Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Journal of Translational Medicine|November 28, 2021
The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profilingIlana Schlam, Sarah E Church, Tyler D Hether, et al.
Breast Cancer Research and Treatment|December 17, 2009
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancerLarissa A Korde, Lara Lusa, Lisa McShane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancerSherry X Yang, Joseph P Costantino, Chungyeul Kim, et al.
The Lancet. Oncology|December 15, 2016
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA studyStephen J Luen, Roberto Salgado, Stephen Fox, et al.
Future Oncology (London, England)|April 13, 2019
IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancerJavier Cortés, Fabrice André, Anthony Gonçalves, et al.
Investigational New Drugs|June 15, 2007
A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancerSheri K Dennison, Samuel A Jacobs, John W Wilson, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 29, 2013
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid TumorsPatrick J Mansky, Dawn B Wallerstedt, Timothy S Sannes, et al.
Research Square|December 11, 2023
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Breast Cancer Research and Treatment|November 25, 2011
Twenty-five year results of the national cancer institute randomized breast conservation trialNicole L Simone, Tu Dan, Joanna Shih, et al.
BMC Bioinformatics|June 19, 2024
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Pageof 19